Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
National Journal of Andrology ; (12): 308-314, 2015.
Article in Chinese | WPRIM | ID: wpr-319503

ABSTRACT

<p><b>OBJECTIVE</b>To explore the diagnosis, treatment, and prognosis of prostatic malignant mesenchymal tumors (PMMT).</p><p><b>METHODS</b>We retrospectively analyzed the clinical and follow-up data about 20 cases of PMMT and reviewed the literature relevant to the diagnosis, treatment, and prognosis of the disease.</p><p><b>RESULTS</b>Based on the results of pathology and immunohistochemistry, the 20 PMMT cases included leiomyosarcoma (n = 7), rhabdomyosarcoma (n = 5), prostatic stromal sarcoma (n = 3), chondrosarcoma (n = 1), and undifferentiated PMMT (n = 4). Twelve of the patients were treated by radical prostatectomy (3 concurrently by sigmoid colostomy and 1 by cystostomy), 2 by pelvic tumor resection following arterial embolization, 1 by total pelvic exenteration, 1 by colostomy with pelvic lymph node biopsy, and 4 by conservative therapy because of metastasis to the lung, pelvis and bone. Of the 20 patients, 9 died of systemic metastasis within 3 months after treatment, 3 died at 6, 7, and 14 months, respectively, 3 survived with tumor for 5, 11, and 12 months, respectively, 2 survived without tumor for 12 and 24 months so far, all subjected to periodic chemotherapy postoperatively, and 3 lost to follow-up.</p><p><b>CONCLUSION</b>PMMT is a tumor of high malignancy and rapid progression, for which transrectal ultrasound-guided biopsy remains the main diagnostic method. The clinical stage of the tumor is an important factor influencing its prognosis and the survival rate of the patients can be improved by early diagnosis and combined therapy dominated by radical prostatectomy.</p>


Subject(s)
Humans , Male , Combined Modality Therapy , Methods , Immunohistochemistry , Mesenchymoma , Mortality , Pathology , Therapeutics , Prognosis , Prostatectomy , Prostatic Neoplasms , Mortality , Pathology , Therapeutics , Retrospective Studies
2.
National Journal of Andrology ; (12): 345-347, 2007.
Article in Chinese | WPRIM | ID: wpr-297726

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the clinical presentation pathologic characteristics, diagnosis and treatment of cystadenoma of the seminal vesicle.</p><p><b>METHODS</b>One case of cystadenoma of the seminal vesicle was analyzed and relevant literature reviewed.</p><p><b>RESULT</b>The patient underwent surgical removal of the right seminal vesicle along with the tumor, which was pathologically confirmed to be cystadenoma of the seminal vesicle. Ultrasonography and CT scanning revealed no recurrence 3 months later.</p><p><b>CONCLUSION</b>Cystadenoma of the seminal vesicle is extremely rare and easily missed in diagnosis. Routine digital rectal examination (DRE) is necessary and ultrasonography and CT scan are helpful to diagnosis. Seminal vesiculectomy with tumor removal is an ideal option with good prognosis.</p>


Subject(s)
Humans , Male , Middle Aged , Cystadenoma , Diagnosis , General Surgery , Genital Neoplasms, Male , Diagnosis , General Surgery , Seminal Vesicles , General Surgery , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL